MX9203405A - Compuestos activos para usarse en el tratamiento de tumores. - Google Patents

Compuestos activos para usarse en el tratamiento de tumores.

Info

Publication number
MX9203405A
MX9203405A MX9203405A MX9203405A MX9203405A MX 9203405 A MX9203405 A MX 9203405A MX 9203405 A MX9203405 A MX 9203405A MX 9203405 A MX9203405 A MX 9203405A MX 9203405 A MX9203405 A MX 9203405A
Authority
MX
Mexico
Prior art keywords
tumors
treatment
active compounds
hand
devapamil
Prior art date
Application number
MX9203405A
Other languages
English (en)
Inventor
Rolf Kretzschmar
Erich Schlick
Michael Eichelbaum
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of MX9203405A publication Critical patent/MX9203405A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9203405A 1986-10-22 1992-06-25 Compuestos activos para usarse en el tratamiento de tumores. MX9203405A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863635930 DE3635930A1 (de) 1986-10-22 1986-10-22 Wirkstoffe zur anwendung bei der behandlung von tumoren

Publications (1)

Publication Number Publication Date
MX9203405A true MX9203405A (es) 1992-08-31

Family

ID=6312239

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203405A MX9203405A (es) 1986-10-22 1992-06-25 Compuestos activos para usarse en el tratamiento de tumores.

Country Status (8)

Country Link
US (1) US5057304A (es)
EP (1) EP0268100B1 (es)
JP (1) JPH0780767B2 (es)
AT (1) ATE64300T1 (es)
AU (1) AU604064B2 (es)
DE (2) DE3635930A1 (es)
MX (1) MX9203405A (es)
ZA (1) ZA877901B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635931A1 (de) * 1986-10-22 1988-04-28 Basf Ag Wirkstoffe zur verhuetung von tumormetastasen
DE3710806A1 (de) * 1987-03-31 1988-10-27 Basf Ag Wirkstoff zur tumorbekaempfung
DE3939372A1 (de) * 1989-11-29 1991-06-06 Knoll Ag Mitonafide-infusionsloesung
JPH04182427A (ja) * 1990-11-16 1992-06-30 Meiji Seika Kaisha Ltd キサントシリンｘジメチルエーテルを含有する抗腫瘍剤
US6911216B1 (en) 1994-10-12 2005-06-28 Genzyme Corporation Targeted delivery via biodegradable polymers
GB9616504D0 (en) * 1996-08-06 1996-09-25 Chiroscience Ltd Therapeutic product and its use
DE19711503C1 (de) 1997-03-19 1998-09-10 Deutsches Krebsforsch Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen
WO1998050018A1 (en) * 1997-05-06 1998-11-12 Xiao Yu Wu Drug delivery system
DE19925810A1 (de) * 1999-06-07 2000-12-14 Paz Arzneimittelentwicklung Anwendung von Verapamil und Verapamilderivaten zur Herstellung von Arzneimitteln mit Glucuronidase hemmender Wirkung
US7423008B2 (en) 2004-03-01 2008-09-09 University Of Kentucky Research Foundation Derivatives of mithramycin and methods of making and uses thereof
US20160067241A1 (en) * 2013-06-13 2016-03-10 Dennis M. Brown Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted naphthalimides such as amonafide for the treatment of immunological, metabolic, infectious, and benign or neoplastic hyperproliferative disease conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE2059985C3 (de) * 1970-12-05 1979-10-04 Knoll Ag, 6700 Ludwigshafen Rechtsdrehende, basisch substituierte Phenylacetonitrile, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2059923C3 (de) * 1970-12-05 1979-01-25 Knoll Ag, 6700 Ludwigshafen l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
JPS5883624A (ja) * 1981-11-12 1983-05-19 Eisai Co Ltd 制癌効果増強剤
DE3344755A1 (de) * 1983-12-10 1985-06-20 Basf Ag, 6700 Ludwigshafen 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten
JPH0753665B2 (ja) * 1984-04-20 1995-06-07 財団法人癌研究会 抗転移剤
DE3635931A1 (de) * 1986-10-22 1988-04-28 Basf Ag Wirkstoffe zur verhuetung von tumormetastasen

Also Published As

Publication number Publication date
US5057304A (en) 1991-10-15
EP0268100B1 (de) 1991-06-12
JPH0780767B2 (ja) 1995-08-30
DE3770766D1 (de) 1991-07-18
EP0268100A1 (de) 1988-05-25
JPS63104918A (ja) 1988-05-10
AU7999787A (en) 1988-04-28
ZA877901B (en) 1989-06-28
AU604064B2 (en) 1990-12-06
DE3635930A1 (de) 1988-04-28
ATE64300T1 (de) 1991-06-15

Similar Documents

Publication Publication Date Title
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
DE3679908D1 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
SE9301951D0 (sv) Methods for administration of taxol
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
IT8548055A1 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IT8748117A0 (it) Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ES2058161T3 (es) Producto activo para la lucha contra tumores.
IT8448710A1 (it) Riduzione degli effetti tossici causati da farmaci antrachinonici
ATE69549T1 (de) Erzeugnisse, enthaltend gallopamil und prazosin.
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
IT1218656B (it) Impiego di composti aventi attivita' mitogena in terapia citostatica
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.